Skip to content
Search

Latest Stories

UK epidemic is slowing; antibody test could soon be ready: Experts

The coronavirus epidemic in the UK is showing signs of slowing and antibody tests could be ready in days, Neil Ferguson, a professor of mathematical biology at Imperial College London, said on Monday (30).

"We think the epidemic is just about slowing in the UK right now," Ferguson told BBC radio.


Patrick Vallance, the government's chief scientific adviser, also said there were signs that locking down the country a week ago had slowed the rate of transmission of the virus. He said Britain was not in a "fast acceleration" phase.

Official data on Monday showed 1,408 patients in the UK who tested positive for coronavirus (COVID-19) had died so far and there were 22,141 positive cases.

Britain initially took a modest approach to containing the spread of the disease compared with European countries such as Italy.

But prime minister Boris Johnson imposed stringent controls after projections showed a quarter of a million people could die. Johnson has since become the first leader of a major power to announce a positive test result for coronavirus.

Vallance said on Monday the restrictions - which have seen public transport use fall to less than a quarter of normal levels - were already having a "big effect" on the transmission of the virus.

This in turn would to lead to fewer people being admitted to hospital, he said, and ultimately reduce the total fatality figure.

Hospital admissions had already stabilised at about 1,000 per day, he said.

"It's quite important - it tells you that actually this is a bit more stable than it has been," he said, adding that the country was tracking France rather than the worse-hit Italy and Spain.

He said it would take another two to three weeks to determine the extent of the slowdown in the spread of the virus because of the lag between the rate of transmission and that of hospital admissions.

Ferguson said a third or even 40 per cent of people do not get any symptoms and thought perhaps two per cent to three per cent of Britain's population had been infected.

But Ferguson cautioned that the data was not good enough to make firm extrapolations.

He said antibody tests were in the final stage of validation and could hopefully be ready in "days rather than weeks".

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less